Insulin pricing is yet another case where state lawmakers can choose whether or not to save the lives of their constituents.
A new rule will soon require most drug ads on TV to state the drug's list price. Here's what the science says about how people will likely react.
It's not just drug manufacturers who are feeling the effects of major opioid lawsuits.
The charges mean that two former Rochester Drug Company leaders could face prison time.
Getting off my antidepressant was hell. I'm not alone—and the pharmaceutical industry isn't helping.
The House Oversight and Reform Committee announced on Monday the launch of an investigation into the pharmaceutical industry's pricing practices.
The government has never fined anyone for breaking a law about reporting clinical trials. A new effort is trying to change that.
Before he was named Trump's health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement.
But the people won't, as the push for pharma reform mounts.
A study confirms that people who make less than $50,000 a year are 37 percent less likely to participate in clinical trials for new cancer treatments—and that's bad news for everybody involved.
Politicians have plenty of ideas to rein in the ever-growing cost of prescription drugs, but for now, the law still favors biotech companies.
Flow restrictors can help prevent children from taking too much acetaminophen, the active ingredient in Tylenol, which can cause liver damage if taken in high doses.
New research finds people suffering from Parkinson’s responded more strongly to a placebo if it was described to them as an expensive drug.
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."